Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Nonobstructive coronary artery disease and risk of myocardial infarction
Thomas M. Maddox
, Maggie A. Stanislawski
, Gary K. Grunwald
, Steven M. Bradley
, P. Michael Ho
, Thomas T. Tsai
, Manesh R. Patel
, Amneet Sandhu
, Javier Valle
, David J. Magid
, Benjamin Leon
,
Deepak L. Bhatt
, Stephan D. Fihn
, John S. Rumsfeld
Research output
:
Contribution to journal
›
Article
›
peer-review
507
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nonobstructive coronary artery disease and risk of myocardial infarction'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Myocardial Infarction
100%
Non-obstructive Coronary Artery Disease
100%
Hazard Ratio
76%
Obstructive Coronary Artery Disease
76%
Coronary Artery Disease
69%
Left Main
30%
Stenosis
30%
Disease Extent
23%
Non-obstructive
15%
Mortality Rate
15%
1-year Mortality
15%
Elective Coronary Angiography
15%
Improved Outcomes
7%
All-cause Mortality
7%
Hospitalization
7%
Angiography
7%
Retrospective Cohort Study
7%
Clinical Significance
7%
Nonfatal Myocardial Infarction
7%
Combined Outcome
7%
US Veterans
7%
Coronary Patients
7%
Risk Adjustment
7%
National Cohort
7%
Veterans Affairs Healthcare System
7%
Angiographic Coronary Artery Disease
7%
Cardiac Adverse Events
7%
Left Main Stenosis
7%
Disease Events
7%
Nursing and Health Professions
Coronary Artery Disease
100%
Heart Infarction
100%
Hazard Ratio
29%
Stenosis
14%
Mortality Rate
5%
All Cause Mortality
5%
Coronary Angiography
5%
Adverse Event
2%
Angiography
2%
Cohort Analysis
2%
Healthcare System
2%
Carbetimer
2%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Coronary Artery Disease
100%
Stenosis
14%
All Cause Mortality
5%
Mortality Rate
5%
Adverse Event
2%
Cohort Study
2%
Carbetimer
2%